I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
A phase II evaluation of gefitinib in the treatment of pers..:
Leslie, Kimberly K
;
Sill, Michael W
;
Fischer, Edgar
...
qt9wt4m6w9. , 2013
Link:
https://escholarship.org/uc/item/9wt4m6w9
RT Journal T1
A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: A Gynecologic Oncology Group study
UL https://suche.suub.uni-bremen.de/peid=base-ftcdlib:oai:escholarship.org:ark:_13030_qt9wt4m6w9&Exemplar=1&LAN=DE A1 Leslie, Kimberly K A1 Sill, Michael W A1 Fischer, Edgar A1 Darcy, Kathleen M A1 Mannel, Robert S A1 Tewari, Krishnansu S A1 Hanjani, Parviz A1 Wilken, Jason A A1 Baron, Andre T A1 Godwin, Andrew K A1 Schilder, Russell J A1 Singh, Meenakshi A1 Maihle, Nita J PB eScholarship, University of California YR 2013 K1 Cancer K1 Clinical Research K1 6.1 Pharmaceuticals K1 Evaluation of treatments and therapeutic interventions K1 Administration K1 Oral K1 Adult K1 Aged K1 80 and over K1 Antineoplastic Agents K1 Biomarkers K1 Tumor K1 Disease-Free Survival K1 Endometrial Neoplasms K1 ErbB Receptors K1 Female K1 Gefitinib K1 Humans K1 Ki-67 Antigen K1 Middle Aged K1 Neoplasm Recurrence K1 Local K1 Protein Kinase Inhibitors K1 Quinazolines K1 Receptors K1 Estrogen K1 Progesterone K1 Signal Transduction K1 Survival Rate K1 Endometrial cancer K1 Epidermal growth factor receptor K1 Soluble EGFR K1 Estrogen receptor K1 Progesterone receptor K1 Oncology and Carcinogenesis K1 Paediatrics and Reproductive Medicine K1 Oncology & Carcinogenesis JF qt9wt4m6w9 LK http://dx.doi.org/https://escholarship.org/uc/item/9wt4m6w9 DO https://escholarship.org/uc/item/9wt4m6w9 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)